Location History:
- Shrub Oak, NY (US) (2001 - 2002)
- Salt Lake City, UT (US) (2005 - 2022)
Company Filing History:
2 out of 116 
2 out of 9 
2 out of 5 
Years Active: 2001-2022
Title: Kirill Ostanin: Innovator in Pharmacological Advances
Introduction
Kirill Ostanin is an accomplished inventor based in Salt Lake City, UT, renowned for his contributions to pharmacology. With a remarkable portfolio of eight patents, Ostanin has significantly impacted the fields of vascular treatment and pharmaceutical compositions.
Latest Patents
Among his notable inventions are patents related to ARF6 inhibitors and their applications. The methods provided in his patents focus on treating various medical conditions, including vascular leak, vascular inflammation, angiogenesis, ocular disorders, and inflammatory disorders. These innovative methods typically involve administering an ADP-ribosylation factor 6 (ARF6) inhibitor, along with new chemical entities and pharmaceutical compositions designed to enhance treatment efficacy. Additionally, Ostanin's patents cover the synthesis and use of ARF6 inhibitors, advancing the pharmaceutical landscape through the development of inhibitors and their corresponding compositions.
Career Highlights
Throughout his career, Kirill Ostanin has worked with notable companies, including Myriad Genetics, Inc. and Cadus Pharmaceutical Corporation. His tenure at these organizations demonstrates his commitment to research and development in the pharmaceutical sector, allowing him to contribute to the advancement of innovative therapeutic solutions.
Collaborations
Ostanin has collaborated with esteemed colleagues, including Lauren Silverman and Thomas Hunsaker. These collaborations have fostered a productive environment for innovation, leading to groundbreaking discoveries in the field of pharmaceutical sciences.
Conclusion
Kirill Ostanin's work exemplifies the spirit of innovation in healthcare. With his numerous patents and collaborations, he continues to make strides in developing novel treatments for complex medical conditions. His contributions will undoubtedly leave a significant mark on the industry, paving the way for future inventions in pharmacology.